These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27547948)

  • 1. Specifying a Conceptual Treatment Choice Relationship Before Analysis Is Necessary for Comparative Effectiveness Research.
    Cozad MJ; Chapman CG; Brooks JM
    Med Care; 2017 Feb; 55(2):94-96. PubMed ID: 27547948
    [No Abstract]   [Full Text] [Related]  

  • 2. The GRACE checklist for rating the quality of observational studies of comparative effectiveness: a tale of hope and caution.
    Dreyer NA; Velentgas P; Westrich K; Dubois R
    J Manag Care Spec Pharm; 2014 Mar; 20(3):301-8. PubMed ID: 24564810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCORI, comparative effectiveness and the ACA: improving patient outcomes or cookbook medicine?
    Fontenot SF
    Physician Exec; 2013; 39(4):98-102. PubMed ID: 23923719
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving confidence in observational studies : should statistical analysis plans be made publicly available?
    Onukwugha E
    Pharmacoeconomics; 2013 Mar; 31(3):177-9. PubMed ID: 23338964
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report.
    Berger ML; Dreyer N; Anderson F; Towse A; Sedrakyan A; Normand SL
    Value Health; 2012; 15(2):217-30. PubMed ID: 22433752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Do You Know Which Health Care Effectiveness Research You Can Trust? A Guide to Study Design for the Perplexed.
    Soumerai SB; Starr D; Majumdar SR
    Prev Chronic Dis; 2015 Jun; 12():E101. PubMed ID: 26111157
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative effectiveness research in cancer with observational data.
    Giordano SH
    Am Soc Clin Oncol Educ Book; 2015; ():e330-5. PubMed ID: 25993193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report outlines best practices in patient-centered outcomes research.
    Wallis L
    Am J Nurs; 2014 Feb; 114(2):16. PubMed ID: 24481351
    [No Abstract]   [Full Text] [Related]  

  • 9. Credibility of observational studies: why public health researchers should care?
    Boccia S
    Eur J Public Health; 2015 Aug; 25(4):554-5. PubMed ID: 26138821
    [No Abstract]   [Full Text] [Related]  

  • 10. Economic evaluations alongside effectiveness trials.
    Jackson JD
    Value Health; 2010 Dec; 13(8):865-6. PubMed ID: 20946185
    [No Abstract]   [Full Text] [Related]  

  • 11. The perils of comparative effectiveness, cost-effectiveness, and value of care research: lessons learned from Washington State.
    Ratliff JK
    Neurosurgery; 2014 Aug; 61 Suppl 1():12-5. PubMed ID: 25032524
    [No Abstract]   [Full Text] [Related]  

  • 12. Critical Appraisal of Observational Designs.
    Quincy B; Ragan P
    J Physician Assist Educ; 2017 Mar; 28(1):49-52. PubMed ID: 28207583
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effectiveness research in cancer: what has been funded and what knowledge gaps remain?
    Glasgow RE; Doria-Rose VP; Khoury MJ; Elzarrad M; Brown ML; Stange KC
    J Natl Cancer Inst; 2013 Jun; 105(11):766-73. PubMed ID: 23578853
    [No Abstract]   [Full Text] [Related]  

  • 14. Observational methods in comparative effectiveness research.
    Concato J; Lawler EV; Lew RA; Gaziano JM; Aslan M; Huang GD
    Am J Med; 2010 Dec; 123(12 Suppl 1):e16-23. PubMed ID: 21184862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCORI in the hot seat. New agency needs to set a bold comparative effectiveness research agenda.
    Goozner M
    Mod Healthc; 2013 Apr; 43(17):24. PubMed ID: 23944135
    [No Abstract]   [Full Text] [Related]  

  • 16. Designing quality health services research: why comparative effectiveness studies are needed and why pharmacists should be involved.
    Carter BL
    Pharmacotherapy; 2010 Aug; 30(8):751-7. PubMed ID: 20653349
    [No Abstract]   [Full Text] [Related]  

  • 17. "Ten commandments" for conducting comparative effectiveness research using "real-world data".
    Willke RJ; Mullins CD
    J Manag Care Pharm; 2011; 17(9 Suppl A):S10-5. PubMed ID: 22074669
    [No Abstract]   [Full Text] [Related]  

  • 18. The Identification Process Using Choice Theory Is Needed to Match Design With Objectives in CER.
    Brooks JM; Chapman CG; Cozad MJ
    Med Care; 2017 Feb; 55(2):91-93. PubMed ID: 27547941
    [No Abstract]   [Full Text] [Related]  

  • 19. On guidelines for comparative effectiveness research using nonrandomized studies in secondary data sources.
    Schneeweiss S
    Value Health; 2009; 12(8):1041. PubMed ID: 19744290
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of absolute risk measurements in observational dermatology studies: important information for decision-making is frequently absent.
    Tjahjono LA; Cline A; Huang WW; Feldman SR
    Br J Dermatol; 2019 Mar; 180(3):678-679. PubMed ID: 30328103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.